A Randomized, Double-blind,Placebo-controlled, Two-way Crossover Study to Evaluate the Effect of Milnacipran on Pain Processing and Functional Magnetic Resonance Imaging Activation Patterns in Patients With Fibromyalgia.
Phase of Trial: Phase IV
Latest Information Update: 13 Nov 2017
At a glance
- Drugs Milnacipran (Primary)
- Indications Fibromyalgia
- Focus Therapeutic Use
- 17 Jan 2012 Planned End Date changed from 1 Jan 2012 to 1 May 2012 as reported by ClinicalTrials.gov.
- 17 Jan 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 14 Aug 2010 New trial record